Pfenex Expression Technology Prima RNApols PeliCRM197
  • About
    • Leadership & Team
    • Our Heritage
    • Careers
  • Offerings
    • Protein Expression
    • mRNA Manufacturing Solutions
    • CRM197
  • Insights
    • Press Releases
    • Resource Center
  • Work With Us

Advancing the manufacture of protein and nucleic acid-based biologic vaccines and therapeutics

by Melanie Venter | Nov 26, 2023 | Articles, Featured

Ligand signed a purchase and sale agreement with Primrose Bio and made an investment of $15m.

BPI News: Primrose Bio Blossoms from Pelican and Primordial Genetics Merger

by Melanie Venter | Sep 19, 2023 | Articles, Featured

The cross-pollination of platforms enables the San Diego-based company to create a novel way of enhancing productivity to enable the next generation of biological therapeutics

About Us
Leadership & Team
Our Heritage
Careers

Therapeutic Protein Solutions
Pfenex Expression Technology®
Pfast™ Feasibility Program
PeliCRM197®
Synthetic Biology

Nucleic Acid Therapeutic Solutions
mRNA Manufacturing Solutions
Prima RNApols™
Evaluate Prima RNApols™
Enzymatic Oligonucleotide Synthesis

Insights

Contact

Terms and Conditions

Privacy Policy

EU Online Dispute Resolution

  • Follow
SIGN UP FOR OUR LATEST NEWS